Tag: heart
-
Boston Scientific to buy Symetis for $435 mln
Boston Scientific is buying Symetis for $435 million in cash. Symetris, of Ecublens, Switzerland, is a medical technology company that makes replacement heart valves. Definitive purchase agreement whereby Boston Scientific will acquire Symetis for $435 million in an all cash, up-front payment Acquisition of Symetis will expand the treatment offerings for patients with aortic valvular heart disease Acquisition projected to close during…